Country Reports

March 01, 2020

Pharmaceutical Executive

With an estimated annual growth rate of 10%, the Middle East is now consistently outpacing traditionally sought-after “pharmerging” heavyweights such as China and Brazil. The United Arab Emirates is at the center of this newfound momentum-asserting its own credentials as a prospective destination for big-ticket foreign investment in healthcare.

August 01, 2018

Pharmaceutical Executive

Behind an economic revival in Portugal, including healthcare spending growth, the nation’s life sciences sector is benefiting as well, with Portugal diverging from the European averages to show an increase in R&D and innovation.

July 01, 2018

Pharmaceutical Executive

The Indian pharmaceutical industry is traditionally known as a global powerhouse for the production of bulk drugs and generics, but less heralded is the growth India has made on the pharma world stage in several other areas, including biotechnology and R&D.

May 01, 2018

Pharmaceutical Executive

Away from the glare of publicity, a tranche of bold reforms in Canada, aimed at harmonizing the national health system and delivering value for money, are fast nearing completion.

April 01, 2018

Pharmaceutical Executive

Still motivated by its challenging, underdog past, Poland has strengthened its economic engine in Europe, where the nation’s pharmaceutical sector is increasingly pursuing enlightened approaches in areas such as market access and evidence-based decision-making.

March 01, 2018

Pharmaceutical Executive

The global importance of the Indian pharmaceutical industry and the affordable generic drugs it produces is indisputable. But despite its evolving international role, India’s domestic healthcare system remains underperforming and undercapitalized.

February 01, 2018

Pharmaceutical Executive

In its ambition to further strengthen the nation’s relationship with the global industry, Brazil holds a valuable, eye-catching asset: the dynamism of its huge pharmaceutical market, the sixth-largest in the world.

January 01, 2018

Pharmaceutical Executive

Three pivotal developments that occurred in 2017 illustrate the growing relevance and influence of the Swiss pharmaceutical and life sciences industry on the world stage. Companies in Switzerland are also playing innovative roles in reshaping the pharma value chain and contemporary paradigm of healthcare provision.

December 01, 2017

Pharmaceutical Executive

Despite having the tenth-largest pharma market in the world and being the birthplace of medical breakthroughs, from insulin to stem cells, Canada seems to be punching below its weight when it comes to health innovation. There are signs, however, that things may be changing as the nation looks to bulk back up.

November 01, 2017

Pharmaceutical Executive

As the global reputation of neighboring pharma giants Switzerland and Germany continues to soar, Austria too is on the move, with the ambition of becoming a real driver and shaper of global medical innovation rather than merely just a link in the chain.